Frontlight ResearchEarly access
CompletedNo phase
The Remote Monitoring of Gout Feasibility Study
Key facts
- Who runs it
- Diakonhjemmet Hospital
- Where
- Norway1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 21 people enrolled
- Started
- 27 Feb 2024
- Ended
- 11 Oct 2024
- Type of study
- Interventional
- Treatments tested
- "Urika", a self-management application for patients with gout
- Record updated
- 11 December 2024
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Male or non-pregnant, non-nursing female >18 years of age at screening
- Patients with a clinical diagnosis of gout
- Patients who fulfil the American College of Rheumatology (ACR)/EULAR classification criteria
- Serum urate level >360 μmol/L at inclusion
- Having a smartphone/tablet
Who cannot take part
- Contraindication for urate lowering therapy
- Major co-morbidities (e.g., malignancies, severe cardiovascular disease, severe diabetes mellitus, severe respiratory diseases)
- Psychiatric or mental disorders, alcohol abuse or other substance abuse, language barriers or other factors which makes adherence to the study protocol difficult
- Unstable medical conditions (e.g,, uncontrollable hypertension, impaired liver function); known stage 3b or higher chronic kidney disease (estimated glomerular filtration (eGFR) rate/creatinine clearance <45 mL/min); severe infection or gastrointestinal bleed
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In this feasibility trial, a digital follow-up treatment strategy with patient self-management app (Urika) and remote monitoring in specialist healthcare for patients with gout will be tested.
The group in the trial
- To determine the feasibility of a patient self-management application (Urika) in patients with gout.Treatment being tested
The intended purpose of the app is to support self-management for patients with gout that initiate urate lowering therapy.
Treatment: "Urika", a self-management application for patients with gout
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The ReMonit Gout Feasibility Study
- Publications
- A self-management app in a digital treat-to-target gout-care approach: the ReMonit Gout feasibility study.Scandinavian journal of rheumatology, 2026
- Record updated
- 11 December 2024